俄羅斯醫(yī)藥行業(yè)20xx年預(yù)測研究報(bào)告-wenkub
2023-04-07 05:00:38 本頁面
【正文】 state drugs segment. The government is also taking the required steps to boost the domestic pharma industry and reduce the dependence on imported products. The Parapharmaceuticals segment has bee one of the leading segments, which has been benefited from the strong young population demand.According to our new research report “Russian Pharma Sector Forecast to 2013”, the Russian pharma sector is projected to show doubledigit growth in near future owing to a rise in investments by the private sector, most importantly the foreign players. Besides, to cater to a large percentage of the population, pharma panies are now shifting their focus towards the research and development projects for manufacturing generic drugs that are less expensive. To understand the direction of the industry, we have done an extensive research and analysis of various segments of the pharma market in the Russian Federation. These segments include: Commercial Drug Segment, State Segment, and the Parapharmaceutical Segment.Growth of the Russian pharmaceutical industry is based on the rising health conscious and consequent rise in the healthcare expenditure of the population. Additionally, rising prevalence of diseases and demand for cheaper drugs will be some of the other important drivers for future growth. The overall improvement in the healthcare industry will also pave way for the Russian pharma market to continue its upward trend during the forecast period (20112013).The report provides precise and reliable information, supplemented with statistics, regarding the Russian pharma sector. The report covers leading drugs, segmentwise break up, and information about major therapy areas. It has thoroughly examined current market trends。 Growth Comparative Analysis Market Segmentation by Expenditur
畢業(yè)設(shè)計(jì)相關(guān)推薦
鄂ICP備17016276號(hào)-1